🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Alice K. Pau

National Institutes of Health

ORCID: 0000-0002-0153-0236

Also affiliated with National Institute of Allergy and Infectious Diseases

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.538Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The impact of the 2014 Ebola epidemic on HIV disease burden and outcomes in Liberia West Africa

PLoS ONE(2021)10.1371/journal.pone.0257049
Top 50%
0.349DataRank
Top 50%5 citations

Ian Wachekwa, Collin Van Ryn, Greg Grandits, Alice K. Pau, Moses Badio +8 more

Papers

Driven by 14 papers — median percentile 42. Top paper: “National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned”.

National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned

Annals of Internal Medicine(2024)10.7326/annals-24-00464
N/A
0.574DataRank · unranked
45 citations

Alice K. Pau, Eric S. Daar, Laura Evans, Rajesh T. Gandhi, Pablo Tebas +61 more

The impact of the 2014 Ebola epidemic on HIV disease burden and outcomes in Liberia West Africa

PLoS ONE(2021)10.1371/journal.pone.0257049
Top 50%
0.349DataRank
Top 50%5 citations

Ian Wachekwa, Collin Van Ryn, Greg Grandits, Alice K. Pau, Moses Badio +8 more

HIV-1 suppression and rare dolutegravir resistance in antiretroviral-experienced people with HIV in Liberia

Communications Medicine(2025)10.1038/s43856-025-00875-x
Top 66%
0.190DataRank
Top 66%2 citations

Alice K. Pau, Safia Kuriakose, Greg Grandits, Cavan Reilly, Brad T. Sherman +25 more

High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for integrase strand transfer inhibitor salvage therapy

AIDS(2022)10.1097/qad.0000000000003288
N/A
0DataRank · unranked
15 citations

Shawn Hill, Jomy George, Alice K. Pau, Safia Kuriakose, Camille M. Lange +9 more

Dramatic improvement of MRI abnormalities of HIV encephalopathy after suppressive antiretroviral therapy

AIDS(2023)10.1097/qad.0000000000003543
N/A
0DataRank · unranked
3 citations

Elizabeth Laidlaw, Dima A. Hammoud, Alice K. Pau, Bryan Smith, Devon K. Dietrich

Pharmacokinetics, Safety, and Tolerability of Once-Daily Darunavir With Cobicistat and Weekly Isoniazid/Rifapentine

JAIDS Journal of Acquired Immune Deficiency Syndromes(2023)10.1097/qai.0000000000003301
N/A
0DataRank · unranked
2 citations

Alice K. Pau, Doris Swaim, Haden T. Bunn, Lilian Adeojo, Charles A. Peloquin +4 more

Ex vivo sensitivity to broadly neutralizing antibodies and anti-CD4 antibody UB-421 of infectious viral isolates from people living with multidrug-resistant HIV

EBioMedicine(2024)10.1016/j.ebiom.2024.105151
N/A
0DataRank · unranked
3 citations

Jana Blažková, J. Shawn Justement, Victoria Shi, Brooke D. Kennedy, Maegan R. Manning +6 more

Statin Therapy as Primary Prevention for Persons With HIV: A Synopsis of Recommendations From the U.S. Department of Health and Human Services Antiretroviral Treatment Guidelines Panel

Annals of Internal Medicine(2025)10.7326/annals-24-03564
N/A
0DataRank · unranked
16 citations

Alice K. Pau, David V. Glidden, Emily P. Hyle, Safia Kuriakose, Seth S. Martin +5 more

Do we need routine integrase resistance testing before starting antiretroviral therapy?

The Lancet HIV(2025)10.1016/s2352-3018(25)00108-0
N/A
0DataRank · unranked
4 citations

Alice K. Pau, Michael D. Miller, Emily P. Hyle, Rami Kantor

Sustained virologic suppression of multidrug-resistant HIV in an individual treated with anti-CD4 domain 1 antibody and lenacapavir

Nature Medicine(2025)10.1038/s41591-024-03357-0
N/A
0DataRank · unranked
4 citations

Jana Blažková, Lela Kardava, J. Shawn Justement, Victoria Shi, Maegan R. Manning +19 more

Utilization of Direct Oral Anticoagulants in People Living with Human Immunodeficiency Virus: Observational Data from the District of Columbia Cohort

Clinical Infectious Diseases(2020)10.1093/cid/ciaa284
N/A
0DataRank · unranked
11 citations

Safia Kuriakose, Anne K. Monroe, Qingjiang Hou, Morgan Byrne, Alice K. Pau +35 more

International Collaboration to Develop and Harmonize Drug Interaction Guidance for Nirmatrelvir/Ritonavir During COVID-19: Lessons Learned for Future Pandemic Preparedness

Clinical Infectious Diseases(2025)10.1093/cid/ciaf606
N/A
0DataRank · unranked
0 citations

Alice Tseng, Sarita D. Boyd, Sara Gibbons, Justin Chiong, Fiona Marra +18 more

Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19

Annals of Internal Medicine(2021)10.7326/m21-1647
N/A
0DataRank · unranked
24 citations

Kanal Singh, Alice K. Pau, Eric S. Daar, Rajesh T. Gandhi, Pablo Tebas +5 more

Polyfunctional Antigen Specific CD4+ T cell Responses in Patients With Human Immunodeficiency Virus/AIDS and Histoplasmosis Immune Reconstitution Inflammatory Syndrome

Clinical Infectious Diseases(2022)10.1093/cid/ciac514
N/A
0DataRank · unranked
5 citations

Afroditi Boulougoura, Nuha Naqvi, Silvia Lucena Lage, Elizabeth Richards, Christopher Grivas +13 more